#PRTC

iGobyBus

@igobybus.bsky.social

2 months ago

PRTC Bus Timings from Pondicherry (Puducherry) Bus Stand Pondicherry is a city in the Union Territory of Pondicherry. The Union Territory of Pondicherry comprises of the erstwhile French colonies viz. Pondicherry, Karaikal, Mahe and Yanam. The Pondicherry a...

Pondicherry Bus Stand Timetable!

Find the complete PRTC Bus timings from Pondicherry Bus Stand. #TicketToGetLost #PRTC #Pondicherry #BusTimings #iGobyBus #BusTravel

www.tickettogetlost.com/2021/11/20/p...

iGobyBus

@igobybus.bsky.social

3 months ago

Coimbatore to Karaikal Bus Timings – PRTC Full Details Coimbatore to Karaikal bus travel distance is around 375 km via Trichy, Thanjavur, Nagapattinam. The Puducherry Road Transport Corporation (PRTC) Karaikal bus depot runs a runs a Express bus service, ...

Coimbatore to Karaikal PRTC Bus Timings

Find the latest Coimbatore to Karaikal Bus Timings along with the route, travel time and fare details. #TicketToGetLost #PRTC #Coimbatore #Karaikal #BusTimings #iGoByBus #BusTravel

www.tickettogetlost.com/2020/09/29/p...

StockTitan

@stocktitan.net

3 months ago

PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis PureTech Health plc, a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, today announced the successful completion of the End-of-Phase 2 meeting with the U.S. Food and Drug Administration regarding the development of deupirfenidone for the treatment of idiopathic pulmonary fibrosis.

#PRTC PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis

www.stocktitan.net/news/PRTC/pure-tech-anno...

Nasdaq

@nasdaq.activitypub.awakari.com.ap.brid.gy

6 months ago

#PRTC #ef723c91-8be4-4bf0-be89-60f5ddedec96 #earningscall-transcripts

Origin | Interest | Match

StockTitan

@stocktitan.net

6 months ago

Biotech Innovation Leader PureTech Health Announces First Half 2025 Financial Results Date and Investor Call PureTech Health (PRTC) will release H1 2025 results on August 28, with analyst presentation at 9:00am EDT/2:00pm BST. Webcast available for investors on company website.

#PRTC PureTech Health: Notice of Half-Yearly Results

www.stocktitan.net/news/PRTC/pure-tech-heal...

StockTitan

@stocktitan.net

7 months ago

PureTech Founded Entity Vedanta Biosciences Announces Phase 2 Study of VE202 in Ulcerative Colitis Did Not Meet Primary Endpoint Vedanta Biosciences, a PureTech (NASDAQ: PRTC) Founded Entity, announced that its Phase 2 COLLECTiVE202 study of VE202 for ulcerative colitis (UC) treatment failed to meet its primary endpoint of endoscopic response. While the treatment was well-tolerated with no serious adverse events, the response rates were not statistically different from placebo.The company will now focus on its lead program VE303, currently in Phase 3 trials for recurrent Clostridioides difficile infection (CDI). VE303 previously showed promising Phase 2 results with a 30.5% absolute risk reduction compared to placebo. The program has received Fast Track and Orphan Drug designations from the FDA. Additionally, Vedanta is advancing VE707 for preventing multidrug-resistant infections, with an IND submission planned for 2026.

#PRTC PureTech Founded Entity Vedanta Biosciences Announces Phase 2 Study of VE202 in Ulcerative Colitis Did Not Meet Primary Endpoint

www.stocktitan.net/news/PRTC/pure-tech-foun...

StockTitan

@stocktitan.net

7 months ago

Former Teva CEO to Lead PureTech's New Respiratory Venture with Phase 3-Ready IPF Breakthrough New subsidiary Celea Therapeutics advances Phase 3-ready deupirfenidone for IPF treatment, led by ex-Teva North America CEO. See development timeline.

#PRTC PureTech Announces the Launch of Celea Therapeutics With a Mission to Transform the Treatment of Respiratory Diseases

www.stocktitan.net/news/PRTC/pure-tech-anno...

iGobyBus

@igobybus.bsky.social

7 months ago

Karaikal to Tiruchendur Bus Timings – PRTC Bus Schedule Find Karaikal to Tiruchendur bus timings, fare, travel time, and route details. Plan your trip with updated PRTC bus timings & booking details.

Karaikal to Tiruchendur Bus Timings!
#Travel #BusTimings #PRTC #iGobyBus #Karaikal #Tiruchendur

www.tickettogetlost.com/2025/07/22/k...

StockTitan

@stocktitan.net

8 months ago

PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private Placement PureTech's (Nasdaq: PRTC) Founded Entity Vor Bio (Nasdaq: VOR) has secured an exclusive global license agreement with RemeGen for telitacicept, a novel dual-target fusion protein, along with a $175 million private placement. The license agreement grants Vor Bio rights outside Greater China and includes an initial payment of $125 million ($45M upfront + $80M in warrants), with potential regulatory and commercial milestones exceeding $4 billion plus tiered royalties.Telitacicept, already approved in China for multiple autoimmune conditions, is currently in global Phase 3 trials with results expected in H1 2027. Additionally, Vor Bio appointed Dr. Jean-Paul Kress as CEO and Chairman, replacing Dr. Robert Ang.The private placement involves issuing warrants for 700 million shares at $0.25 per warrant, closing expected on June 27, 2025.

#PRTC #VOR PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private Placement

www.stocktitan.net/news/PRTC/pure-tech-foun...

StockTitan

@stocktitan.net

8 months ago

PureTech Health: Results of Annual General Meeting PureTech Health (Nasdaq: PRTC, LSE: PRTC) held its Annual General Meeting on June 16, 2025, where all proposed resolutions were successfully passed. Notable outcomes include the approval of the 2024 Annual Report with 99.97% support, and the re-election of multiple directors including Dr. Robert Langer (95.43% approval) and Dr. Raju Kucherlapati (90.88% approval). Two resolutions received less than 80% approval: the Directors' Remuneration Report (72.49%) and the re-election of Ms. Kiran Mazumdar-Shaw (72.65%). The Board acknowledged these results and committed to continued shareholder engagement, promising an update within six months. Other key approvals included PricewaterhouseCoopers LLP's reappointment as auditors, authorization for share allotment, and approval for market purchase of own shares.

#PRTC PureTech Health: Results of Annual General Meeting

www.stocktitan.net/news/PRTC/pure-tech-heal...

StockTitan

@stocktitan.net

9 months ago

PureTech’s Deupirfenidone (LYT-100) Demonstrates Strong and Durable Efficacy as a Monotherapy with Favorable Tolerability in Phase 2b ELEVATE IPF Trial PureTech Health (PRTC) presented promising Phase 2b ELEVATE IPF trial results for deupirfenidone (LYT-100) at the 2025 ATS Conference. The drug demonstrated significant efficacy in treating idiopathic pulmonary fibrosis (IPF). At 825 mg TID dosing, deupirfenidone showed an 80.9% treatment effect vs. placebo, approximately 50% greater than pirfenidone's 54.1% effect. The drug slowed lung function decline to -21.5 mL over 26 weeks and preliminary 52-week data showed -32.8 mL decline, comparable to healthy older adults' natural decline. Importantly, deupirfenidone maintained favorable tolerability despite 50% higher drug exposure compared to pirfenidone. PureTech plans to meet with the FDA by Q3 2025 and aims to initiate Phase 3 trials by year-end.

#PRTC PureTech’s Deupirfenidone (LYT-100) Demonstrates Strong and Durable Efficacy as a Monotherapy with Favorable Tolerability in Phase 2b ELEVATE IPF Trial

www.stocktitan.net/news/PRTC/pure-tech-s-de...

StockTitan

@stocktitan.net

10 months ago

PureTech Announces Publication of New Research Highlighting Untold Experiences of People Living with Idiopathic Pulmonary Fibrosis (IPF) PureTech Health (NASDAQ: PRTC) has published new research in BMC Pulmonary Medicine revealing critical insights into the experiences of people living with Idiopathic Pulmonary Fibrosis (IPF). The study, conducted with 106 IPF patients across the US, highlighted significant challenges in diagnosis, treatment, and quality of life.Key findings include varied diagnosis timelines with frequent delays, low antifibrotic treatment uptake, and challenges in managing multiple health conditions. Nearly 90% of participants reported managing additional health challenges alongside IPF. The research also revealed that while supplemental oxygen therapy provides symptom relief, patients face logistical, financial, and emotional challenges.The study, led by Dr. Camilla Graham and conducted in collaboration with experts from the University of Alabama, Vanderbilt University Medical Center, and the Pulmonary Fibrosis Foundation, emphasizes the need for enhanced disease awareness, streamlined diagnosis, and patient-centered treatment approaches.

#PRTC PureTech Announces Publication of New Research Highlighting Untold Experiences of People Living with Idiopathic Pulmonary Fibrosis (IPF)

www.stocktitan.net/news/PRTC/pure-tech-anno...

iGobyBus

@igobybus.bsky.social

10 months ago

PRTC Local Bus Timings from Puducherry Bus Stand Get the PRTC bus timings from Puducherry to local places and villages. Plan your PRTC bus journey with the updated Puducherry Bus Stand timetable.

Local Bus Timings from Puducherry Bus Stand!
#travel #PRTC #BusTimings #iGobyBus #Explore #citytravel #Pondicherry

www.tickettogetlost.com/2025/04/29/p...

iGobyBus

@igobybus.bsky.social

10 months ago

Puducherry to Mahe Bus Timings | PRTC Ultra Deluxe Get Puducherry to Mahe bus timings, route, travel time, & bus fare. details. Plan your trip with PRTC Puducherry to Mahe and Mahe to Puducherry bus timings.

Puducherry to Mahe Bus Timings!
#Travel #PRTC #BusTimings #iGobyBus #Explore #Mahe

www.tickettogetlost.com/2025/04/28/p...

Market Wire News

@marketwirenews.com

11 months ago

News; ( NASDAQ: #PRTC ) PureTech Appoints Peel Hunt as Joint UK Corporate Broker

iGobyBus

@igobybus.bsky.social

1 year ago

Puducherry to Velankanni Bus Timings | PRTC PY 01 DC 0401 Puducherry to Velankanni bus travel distance is around 160 km via Karaikal. The Puducherry Road Transport Corporation (PRTC) Puducherry bus depot runs a Express bus service, providing public travel op...

Puducherry to Velankanni Bus Timings!
#Travel #PRTC #BusTimings #iGobyBus

www.tickettogetlost.com/2025/02/24/p...

YesPunjab.com

@handle.invalid

1 year ago

Laljit Bhullar Discusses Policy for Regularizing Temporary Employees of Roadways & PRTC with AG, Punjab - Yes Punjab News Punjab Transport Minister S. Laljit Singh Bhullar meets Advocate General to discuss regularization of temporary employees in Punjab Roadways and PRTC for job security.

Laljit Bhullar Discusses Policy for Regularizing Temporary Employees of Roadways & PRTC with AG, Punjab yespunjab.com?p=94756

#LaljitBhullar #PunjabRoadways #PRTC #TemporaryEmployees #PolicyDiscussion #PunjabGovernment #PublicTransport #EmployeeRegularization #PunjabNews #GovernmentInitiatives

StockTitan

@stocktitan.net

1 year ago

PureTech's Vedanta Reports Breakthrough 80% CDI Reduction in Phase 2 Trial Results Groundbreaking Phase 2 data shows VE303 bacterial treatment dramatically cuts C. difficile infection recurrence through multiple mechanisms. Phase 3 trial underway.

#PRTC PureTech Founded Vedanta Biosciences Publishes Additional Phase 2 VE303 Results in Nature Medicine

www.stocktitan.net/news/PRTC/pure-tech-foun...

StockTitan

@stocktitan.net

1 year ago

PureTech's Cancer Drug LYT-200 Secures FDA Fast Track Status for Leukemia Treatment FDA grants Fast Track designation to PureTech's LYT-200 for acute myeloid leukemia, advancing their novel anti-galectin-9 antibody showing promising clinical activity.

#PRTC PureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML)

www.stocktitan.net/news/PRTC/pure-tech-rece...

Market Wire News

@marketwirenews.com

1 year ago

Breaking News: ( NASDAQ: #PRTC ) PureTech Appoints UBS as UK Corporate Broker

YesPunjab.com

@handle.invalid

1 year ago

Punjab Transport Minister Laljit Bhullar Orders Purchase of New Buses - Yes Punjab News Punjab Transport Minister Laljit Singh Bhullar orders inclusion of new buses, curbs private operators' monopoly, enhances revenue, and ensures free bus service for women.

Punjab Transport Minister Laljit Bhullar Orders Purchase of New Buses yespunjab.com?p=78292

#PunjabTransport #LaljitSinghBhullar #PunjabRoadways #PRTC #PublicTransport #NewBuses #GovernmentRevenue #WomenFreeBusService #TransportUpdates #PunjabNews

YesPunjab.com

@handle.invalid

1 year ago

Punjab Transport Dept Recorded 10.91% Revenue Growth in 2024: Laljit Bhullar - Yes Punjab News Punjab Transport Minister Laljit Singh Bhullar reports a revenue growth of Rs.349 crore in 2024, highlighting initiatives like free travel for women and transport infrastructure upgrades.

Punjab Transport Dept Recorded 10.91% Revenue Growth in 2024: Laljit Bhullar yespunjab.com?p=77862

#PunjabTransport #RevenueGrowth #PublicTransport #FreeTravel #WomenEmpowerment #PRTC #PUNBUS #RoadwaysExpansion #InfrastructureDevelopment #TransportInnovation #PunjabDevelopment #LaljitBhullar

Market Wire News

@marketwirenews.com

1 year ago

NEWS: ( NASDAQ: #PRTC ) PureTech's Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondary Endpoints in the ELEVATE IPF Phase 2b Trial

#StockMarket #News

marketshareai.uk

@marketshareai.bsky.social

1 year ago

🧬 Deupirfenidone from @PureTechHealth shows promise as potential new standard IPF treatment. Positive Phase 2b trial results for novel therapy in idiopathic pulmonary fibrosis patients. #biotech

Get ahead with today's top stories 👇

https://marketshareai.uk/news/lse/prtc/1961Q

#PRTC #AIM #FTSE

StockTitan

@stocktitan.net

1 year ago

Seaport's Depression Drug Shows Promise: Phase 1 Data Reveals 9x Higher Blood Levels vs Standard Treatment New clinical data shows Seaport's SPT-300 depression treatment achieves significantly higher blood levels with favorable safety profile, paving way for Phase 2b trials.

#PRTC PureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024

#news #StockMarket #stocks

www.stocktitan.net/news/PRTC/pure-tech-foun...

StockTitan

@stocktitan.net

1 year ago

PureTech's LYT-200 Shows Promising Results in Phase 1b Leukemia Trial with 80% Disease Control Rate PureTech's LYT-200 demonstrates strong efficacy in treating resistant leukemia, achieving 80% disease control rate in combination therapy with favorable safety profile in Phase 1b trial.

#PRTC PureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the 2024 ASH Annual Meeting

#stocks #investing #news

www.stocktitan.net/news/PRTC/pure-tech-pres...

YesPunjab.com

@handle.invalid

1 year ago

Punjab's first PRTC Sub-Depot to come up in Gidderbaha: Laljit Bhullar - Yes Punjab News S. Laljit Singh Bhullar announces the development of PRTC's first sub-depot in Gidderbaha and a solar power project, aiming to improve transportation infrastructure in Punjab.

Punjab's first PRTC Sub-Depot to come up in Gidderbaha: Laljit Bhullar yespunjab.com?p=68866

#PunjabRoadways #PublicTransportation #InfrastructureDevelopment #PRTC #GidderbahaSubDepot #SustainableTransport #SolarEnergy #SolarPower #TransportMinister #PunjabProgress #SelfEmployment #LaljitBhullar

StockTitan

@stocktitan.net

1 year ago

#PRTC PureTech Founded Entity Seaport Therapeutics Adds Sandi Peterson to its Board of Directors

www.stocktitan.net/news/PRTC/pure-tech-foun...

Market Wire News

@marketwirenews.com

1 year ago

JUST IN: ( NASDAQ: #PRTC ) PureTech Presents Research Highlighting Burden of Idiopathic Pulmonary Fibrosis (IPF) and Use of a Bayesian Statistical Analysis for LYT-100 (Deupirfenidone) at CHEST 2024 Annual Meeting

#StockMarket #News

Market Wire News

@marketwirenews.com

1 year ago

Just In: ( NASDAQ: #PRTC ) PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults

#StockMarket #News